(0.08%) 5 521.50 points
(0.13%) 39 895 points
(0.17%) 19 785 points
(-0.06%) $81.58
(0.68%) $2.83
(-0.28%) $2 337.80
(0.07%) $29.55
(0.43%) $1 006.10
(0.05%) $0.932
(-0.09%) $10.52
(0.01%) $0.788
(-0.81%) $87.28
-96.33% $ 0.00110
Live Chart Being Loaded With Signals
eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer...
Stats | |
---|---|
Dzisiejszy wolumen | 1.33M |
Średni wolumen | 0 |
Kapitalizacja rynkowa | 220 166 |
EPS | $-2.16 ( Q1 | 2024-05-09 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
0 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.00100 (90.91%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-11-27 | Sr One Capital Management, Llc | Sell | 430 578 | Common Stock |
2023-11-27 | Sr One Capital Management, Llc | Sell | 178 585 | Common Stock |
2023-11-15 | Worland Stephen T | Buy | 5 979 | Common Stock |
2023-11-15 | Byrnes Michael | Buy | 4 524 | Common Stock |
2023-09-09 | Loewy Caroline M | Buy | 40 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
29.02 |
Last 94 transactions |
Buy: 4 047 347 | Sell: 1 063 888 |
eFFECTOR Therapeutics, Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
eFFECTOR Therapeutics, Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-111 000 (0.00 %) |
EPS: | $-16.37 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-111 000 (0.00 %) |
EPS: | $-16.37 |
FY | 2022 |
Przychody: | $3.55M |
Zysk brutto: | $3.50M (98.51 %) |
EPS: | $-7.85 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $0 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
eFFECTOR Therapeutics,
eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer. The company is also developing zotatifin, a small molecule designed to inhibit eukaryotic initiation factor 4A (eIF4E), which is in Phase 1/2 clinical trial to treat patients with solid tumors and in combination with fulvestrant and abemaciclib in a Phase 2a open-label expansion cohort to treat patients with ER+ breast cancer. eFFECTOR Therapeutics, Inc. has a research collaboration and license agreement with Pfizer Inc. to develop inhibitors of eIF4E. eFFECTOR Therapeutics, Inc. was incorporated in 2012 and is headquartered in Solana Beach, California.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej